Caspian Journal of Pediatrics (Sep 2016)
Tacrolimus and diabetic ketoacidosis after kidney transplantation in a 15-year-old girl (Case Report)
Abstract
Tacrolimus is a main drug for induction and maintenance immunosuppression for patients with kidney transplants in many centers. One of important side effect of drug is post-transplant diabetes mellitus. Of course, diabetes ketoacidosis (DKA) is rare. In this report, a 12-year-old girl with DKA was presented after 45 days of kidney transplantation.